Upcoming Events
TIL Therapies Summit
Boston, Massachusetts
17-19 November 2026
News
Press release - Scinus Secures €3 Million Strategic Investment to Accelerate Global
Roll-Out of the Osilaris™ Cell Expansion Platform.
Scinus Group today announced the successful closing of a €3 million strategic investment round led by Myosotis Investments. Existing shareholders, including the company’s founders and the Demcon Innovation Fund, also participated in the round...
Press release - Scinus Secures €3 Million Strategic Investment to Accelerate Global
Roll-Out of the Osilaris™ Cell Expansion Platform.
Scinus Group today announced the successful closing of a €3 million strategic investment round led by Myosotis Investments. Existing shareholders, including the company’s founders and the Demcon Innovation Fund, also participated in the round..
Scinus wins PRIX GALIEN medtech innovation AWARD 2022
Scinus wins PRIX GALIEN medtech innovation AWARD. At the 28th presentation of the Prix Galien Nederland Awards 2022, the Prix Galien MedTech Innovation Award was presented for the 4th time. Scinus Cell Expansion - a Demcon Investment company - received the MedTech...
Scinus Cell Expansion B.V. has been recognized as one of the Top Cell And Gene Therapy Companies In Europe by Life Sciences Review.
Osilaris simplifies operational procedures and significantly diminishes the overall cost of ownership.
Press release - Dutch Danish collaboration on cell therapy
Developing an efficient cell therapy production platform togetherPRESS RELEASE Bilthoven (NL)/Aarhus (DK), July 2023 Dutch-Danish collaboration on cell therapy Cell therapy, which uses cultured human cells, is a promising treatment option for a wide range of diseases....
Erik Vossenaar new Managing Director of Scinus Cell Expansion
Scinus Cell Expansion is pleased to announce that as of 1 January 2025, Dr. Erik Vossenaar has taken up the role of Managing Director of the company. Erik Vossenaar adds: “I am very much looking forward to working together with the Scinus team towards realizing the mission to make cell-based therapies accessible for patients around the world.
Press release - Scinus Cell Expansion Announces Rebranding of SCINUS bioreactor NG to Osilaris™.
Scinus Cell Expansion, a leader in scalable bioreactor solutions for cell therapy manufacturing, announces the rebranding of its flagship SCINUS bioreactor NG. Moving forward, the system will be known as Osilaris™...
Scinus Cell Expansion and ATMP-Center at Skåne University Hospital Partner for Advances in Cell Therapy
Together, our aim is to drive innovation and progress in the field of cell and gene therapy. The milestone was celebrated in the presence of Dutch Minister for Foreign Trade, Reinette Klever, and VNO-NCW Chair, Ingrid Thijssen.
Scinus new location in Utrecht Science Park.
From 19 October 2026, Scinus Cell Expansion will be based in the PlusUltra building at Utrecht Science Park. We’re moving from Zeist to a new home where we look forward to welcoming customers, partners, and collaborators...
Press release - Scinus establishes new headquarters at Utrecht Science Park.
Scinus announces that it will move its headquarters and laboratory operations to Plus Ultra Utrecht at Utrecht Science Park, effective 19 October 2026. The new laboratory and office facilities will support the company’s continued development ...